Oxford Biomedica plc (OXB.L)
OXB.L Stock Price Chart
Explore Oxford Biomedica plc interactive price chart. Choose custom timeframes to analyze OXB.L price movements and trends.
OXB.L Company Profile
Discover essential business fundamentals and corporate details for Oxford Biomedica plc (OXB.L) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
13 Dec 1996
Employees
850.00
Website
https://www.oxb.comCEO
Frank Mathias
Description
Oxford Biomedica plc, a biopharmaceutical company, engages in the research, development, and bioprocessing of cell and gene therapy products in Europe and internationally. The company operates in two segments, Platform and Product. Its LentiVector platform technology integrates genes into non-dividing cells, including neurons in the brain and retinal cells in the eye, as well as accommodates various therapeutic genes. The company's products under development stage include Axo-Lenti-PD, a gene-based treatment for parkinson's disease; OXB-302, which is in pre-clinical stage for the treatment of haematological tumours; OXB-401 that is in pre-clinical stage for the treatment of liver indication; OXB-40X for liver indication; and OXB-40Y for liver indication. The company has partnerships with Novartis, Bristol Myers Squibb, Sio Gene Therapies, Orchard Therapeutics, Boehringer Ingelheim, the UK Cystic Fibrosis Gene Therapy Consortium, Immatics, Arcellx, and Vaccines Manufacturing and Innovation Centre. The company also has a research collaboration agreement with Circularis Biotechnologies to identify novel tissue specific promoters for in vivo lentiviral gene therapy products; Virica Biotech for scaling of viral medicines; Isolere Bio provides a platform technology for tackling downstream inefficiencies in the manufacturing of biologics; and BiologIC Technologies provides novel biocomputer system for viral vector development. Oxford Biomedica plc was founded in 1995 and is headquartered in Oxford, the United Kingdom.
OXB.L Financial Timeline
Browse a chronological timeline of Oxford Biomedica plc corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 7 Apr 2026
Upcoming earnings on 22 Sept 2025
Earnings released on 9 Apr 2025
EPS came in at -£0.10 falling short of the estimated -£0.08 by -31.21%, while revenue for the quarter reached £77.99M, beating expectations by +1.02%.
Earnings released on 23 Sept 2024
EPS came in at -£0.31 falling short of the estimated -£0.28 by -9.51%, while revenue for the quarter reached £50.81M, beating expectations by +0.61%.
Earnings released on 29 Apr 2024
EPS came in at -£1.13 falling short of the estimated -£0.49 by -130.49%, while revenue for the quarter reached £46.48M, missing expectations by -2.15%.
Earnings released on 20 Sept 2023
EPS came in at -£0.50 falling short of the estimated -£0.36 by -38.78%, while revenue for the quarter reached £43.06M, missing expectations by -30.77%.
Earnings released on 25 Apr 2023
EPS came in at -£0.14 falling short of the estimated -£0.07 by -113.93%, while revenue for the quarter reached £75.96M, beating expectations by +15.44%.
Earnings released on 30 Jun 2022
EPS came in at -£0.27 falling short of the estimated -£0.10 by -161.79%, while revenue for the quarter reached £64.03M, beating expectations by +4.19%.
Earnings released on 31 Dec 2021
EPS came in at £0.01 falling short of the estimated £0.08 by -89.59%, while revenue for the quarter reached £61.55M, missing expectations by -18.40%.
Earnings released on 30 Jun 2021
EPS came in at £0.21 surpassing the estimated £0.06 by +256.00%, while revenue for the quarter reached £81.25M, missing expectations by -0.55%.
Earnings released on 31 Dec 2020
EPS came in at £0.01 surpassing the estimated -£0.00 by +275.67%, while revenue for the quarter reached £53.75M, beating expectations by +7.50%.
OXB.L Stock Performance
Access detailed OXB.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.